| Year |
Citation |
Score |
| 2024 |
Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Bergé E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, Sène D, Dieudé P, Couderc M, Fauchais AL, et al. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts. The Lancet. Rheumatology. PMID 38437852 DOI: 10.1016/S2665-9913(23)00340-5 |
0.399 |
|
| 2024 |
Astouati Q, Machet T, Houssais C, Noury JB, Allenbach Y, Gallay L, Quere B, Assan F, Benveniste O, Broner J, Duffau P, Espitia A, Grasland A, Hayem G, Guern VL, ... ... Nocturne G, et al. Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis. Rheumatology (Oxford, England). PMID 38430004 DOI: 10.1093/rheumatology/keae129 |
0.438 |
|
| 2024 |
Meudec L, Debray MP, Beurnier A, Marques C, Juge PA, Dhote R, Larroche C, Fauchais AL, Dernis E, Vittecoq O, Saraux A, Gottenberg JE, Hachulla E, Le Guern V, Dieudé P, ... ... Nocturne G, et al. Characterisation of airway disease associated with Sjögren disease. Rmd Open. 10. PMID 38428976 DOI: 10.1136/rmdopen-2023-003866 |
0.383 |
|
| 2023 |
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, et al. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study. The Lancet. Rheumatology. 5: e330-e340. PMID 38251600 DOI: 10.1016/S2665-9913(23)00099-1 |
0.338 |
|
| 2023 |
Pezot M, Nocturne G, Belkhir R, Henry J, Pavy S, Seror R, Mariette X, Bitoun S. Obinutuzumab in patients with Sjogren's disease immunised against rituximab. Annals of the Rheumatic Diseases. PMID 37945315 DOI: 10.1136/ard-2023-224999 |
0.422 |
|
| 2023 |
Kachaner A, Bergé E, Desmoulins F, Le Pajolec C, Rousseau A, Labetoulle M, Nocturne G, Mariette X, Seror R. Comparison between primary Sjögren's disease patients with high or low level of dryness. Rmd Open. 9. PMID 37899092 DOI: 10.1136/rmdopen-2023-003291 |
0.422 |
|
| 2023 |
Nocturne G, Marmontel O, di Filippo M, Chretien P, Krzysiek R, Lifermann F, Rahal N, Belkhir R, Moulin P, Mariette X. Efficacy of daratumumab in refractory primary Sjögren disease. Rmd Open. 9. PMID 37730313 DOI: 10.1136/rmdopen-2023-003464 |
0.368 |
|
| 2023 |
Paoletti A, Ly B, Cailleau C, Gao F, Péan de Ponfilly-Sotier M, Pascaud J, Rivière E, Yang L, Nwosu L, Elmesmari A, Reynaud F, Hita M, Paterson D, Reboud J, Fay F, ... Nocturne G, et al. Liposomal AntagomiR-155-5p restores anti-inflammatory macrophages and improves arthritis in pre-clinical models of Rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37527031 DOI: 10.1002/art.42665 |
0.386 |
|
| 2023 |
Devauchelle-Pensec V, Mariette X, Benyoussef AA, Boisrame S, Cochener B, Cornec D, Nocturne G, Gottenberg JE, Hachulla E, Labalette P, Le Guern V, M'Bwang Seppoh R, Morel J, Orliaguet M, Saraux A, et al. French national diagnostic and care protocol for Sjögren's disease. La Revue De Medecine Interne. 44: 423-457. PMID 37453854 DOI: 10.1016/j.revmed.2023.07.001 |
0.763 |
|
| 2023 |
Nocturne G, Mariette X. Expert Perspective: Challenges in Sjögren's Disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37229641 DOI: 10.1002/art.42612 |
0.379 |
|
| 2023 |
Duret PM, Schleiss C, Kawka L, Meyer N, Ye T, Saraux A, Devauchelle-Pensec V, Seror R, Larroche C, Perdriger A, Sibilia J, Vallat L, Fornecker LM, Nocturne G, Mariette X, et al. Bruton's tyrosine kinase (BTK) gene overexpression is associated with risk of lymphoma in primary Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37115807 DOI: 10.1002/art.42550 |
0.416 |
|
| 2023 |
Beydon M, Seror R, Le Guern V, Chretien P, Mariette X, Nocturne G. Impact of patient ancestry on heterogeneity of Sjögren's disease. Rmd Open. 9. PMID 36878621 DOI: 10.1136/rmdopen-2022-002955 |
0.453 |
|
| 2023 |
Rivière E, Chivasso C, Pascaud J, Bechara R, Ly B, Delporte C, Mariette X, Nocturne G. Hyperosmolar environment and salivary gland epithelial cells increase extra-cellular matrix remodeling and lymphocytic infiltration in Sjögren's syndrome. Clinical and Experimental Immunology. PMID 36759947 DOI: 10.1093/cei/uxad020 |
0.388 |
|
| 2023 |
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, ... ... Nocturne G, et al. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nature Communications. 14: 598. PMID 36737443 DOI: 10.1038/s41467-023-36369-4 |
0.359 |
|
| 2023 |
Nocturne G, Mariette X. Interferon signature in systemic autoimmune diseases: what does it mean? Rmd Open. 8. PMID 36597991 DOI: 10.1136/rmdopen-2022-002687 |
0.362 |
|
| 2022 |
Meudec L, Richebé P, Pascaud J, Mariette X, Nocturne G. Janus kinase inhibitors alter NK cells phenotype and inhibit their antitumor capacity. Rheumatology (Oxford, England). PMID 36583542 DOI: 10.1093/rheumatology/keac710 |
0.359 |
|
| 2022 |
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, ... ... Nocturne G, et al. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nature Communications. 13: 6519. PMID 36316359 DOI: 10.1038/s41467-022-34311-8 |
0.359 |
|
| 2022 |
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, ... ... Nocturne G, et al. Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nature Communications. 13: 4287. PMID 35896530 DOI: 10.1038/s41467-022-30773-y |
0.382 |
|
| 2022 |
Urbain F, Ferlicot S, Rocher L, Besson FL, Gomez L, Michot JM, Lazure T, Mariette X, Nocturne G, Lambotte O, Zaidan M, Noel N. Renal involvement of lymphomas proven by kidney biopsy: report of 10 cases from a tertiary care center and comparison with the literature. International Journal of Hematology. PMID 35829895 DOI: 10.1007/s12185-022-03411-y |
0.401 |
|
| 2022 |
Da Cunha E, Mariette X, Desmoulins F, Bergé E, Nocturne G, Benmalek A, Haigh O, Seror R, Labetoulle M, Rousseau A. Associations between ocular and extra-ocular assessment in primary Sjögren's syndrome. Joint Bone Spine. 89: 105426. PMID 35716880 DOI: 10.1016/j.jbspin.2022.105426 |
0.438 |
|
| 2022 |
Bitoun S, Avouac J, Henry J, Ghossan R, Al Tabaa O, Belkhir R, Nocturne G, Mariaggi AA, Rozenberg F, Vauloup-Fellous C, Mariette X, Seror R. Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses. Rmd Open. 8. PMID 35589332 DOI: 10.1136/rmdopen-2022-002308 |
0.327 |
|
| 2022 |
Kedra J, Seror R, Dieudé P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Fautrel B, ... ... Nocturne G, et al. Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma. Joint Bone Spine. 105390. PMID 35490943 DOI: 10.1016/j.jbspin.2022.105390 |
0.558 |
|
| 2022 |
Paoletti A, Ly B, Bitoun S, Nocturne G, Rivière E, Manson JJ, Matucci A, Pallardy M, De Vries N, Mariette X. Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis. Frontiers in Immunology. 13: 832117. PMID 35281074 DOI: 10.3389/fimmu.2022.832117 |
0.367 |
|
| 2022 |
Hassold N, Seror R, Mariette X, Nocturne G. Characteristics of Sjögren's syndrome associated with rheumatoid arthritis. Rmd Open. 8. PMID 35177557 DOI: 10.1136/rmdopen-2022-002234 |
0.438 |
|
| 2022 |
Cachen L, Nocturne G, Collins M, Meyer A, Gleizes A, Hacein-Bey-Abina S, Carbonnel F, Mariette X, Seror R. Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF. Rmd Open. 8. PMID 35091460 DOI: 10.1136/rmdopen-2021-001697 |
0.432 |
|
| 2021 |
Parreau S, Nocturne G, Mariette X, Burroni B, Lazure T, Besson FL, Régent A, Mouthon L, Terrier B, Seror R, Le Guern V. Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients. Rheumatology (Oxford, England). PMID 34940802 DOI: 10.1093/rheumatology/keab949 |
0.454 |
|
| 2021 |
Rivière E, Pascaud J, Mariette X, Nocturne G. Response to «Are Salivary Gland Epithelial Cells the Main Source of Increased IL-7 in Primary Sjögren's Syndrome?» by Caiqun Chen et al. Arthritis & Rheumatology (Hoboken, N.J.). PMID 34694060 DOI: 10.1002/art.42004 |
0.371 |
|
| 2021 |
Kedra J, Seror R, Dieudé P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Goupille P, ... ... Nocturne G, et al. Lymphoma complicating rheumatoid arthritis: results from a French case-control study. Rmd Open. 7. PMID 34470830 DOI: 10.1136/rmdopen-2021-001698 |
0.58 |
|
| 2021 |
Bitoun S, Nocturne G, Seror R, Mariette X. Clinically effective concentration and risk of hydroxychloroquine retinopathy in Systemic Lupus Erythematosus : Walking on a thin line. Arthritis Care & Research. PMID 34459156 DOI: 10.1002/acr.24776 |
0.325 |
|
| 2021 |
Seror R, Nocturne G, Mariette X. Current and future therapies for primary Sjögren syndrome. Nature Reviews. Rheumatology. PMID 34188206 DOI: 10.1038/s41584-021-00634-x |
0.417 |
|
| 2021 |
Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, et al. Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88: 105221. PMID 34183155 DOI: 10.1016/j.jbspin.2021.105221 |
0.452 |
|
| 2021 |
Tournadre A, Sellam J, Morel J, Jullien D, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Goupille P, Kluger N, Lazaro E, Goff BL, Lédinghen V, Lequerré T, Nocturne G, Seror R, et al. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88: 105210. PMID 34074455 DOI: 10.1016/j.jbspin.2021.105210 |
0.454 |
|
| 2021 |
Sellam J, Morel J, Tournadre A, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Jullien D, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, et al. PRACTICAL MANAGEMENT of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88: 105174. PMID 33992225 DOI: 10.1016/j.jbspin.2021.105174 |
0.457 |
|
| 2021 |
Nocturne G, Ly B, Paoletti A, Pascaud J, Seror R, Nicco C, Mackay F, Vincent FB, Lazure T, Ferlicot S, Stimmer L, Pascal Q, Roulland S, Krzysiek R, Hacein-Bey S, et al. Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice. Clinical and Experimental Immunology. PMID 33864242 DOI: 10.1111/cei.13602 |
0.422 |
|
| 2021 |
Kedra J, Nocturne G, Mariette X, Seror R. Inflammation-targeted therapies and cancer. Joint Bone Spine. 88: 105176. PMID 33771759 DOI: 10.1016/j.jbspin.2021.105176 |
0.349 |
|
| 2021 |
Dupré A, Pascaud J, Rivière E, Paoletti A, Ly B, Mingueneau M, Mariette X, Nocturne G. Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome. Rmd Open. 7. PMID 33688082 DOI: 10.1136/rmdopen-2020-001442 |
0.414 |
|
| 2021 |
Bonnet I, Rousseau A, Duraffour P, Pouchot J, Nguyen CD, Gabison E, Seror R, Marotte H, Mariette X, Nocturne G. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis. Rmd Open. 7. PMID 33510042 DOI: 10.1136/rmdopen-2020-001472 |
0.386 |
|
| 2021 |
Martin de Fremont G, Chiron A, Krzysiek R, Hacein-Bey-Abina S, Mariette X, Nocturne G. Flare of a mixed cryoglobulinaemic vasculitis after obinutuzumab infusion. Clinical and Experimental Rheumatology. PMID 33506759 |
0.433 |
|
| 2020 |
Rivière E, Mariette X, Nocturne G. Response to: 'Role of interaction between B cells and epithelial cells in pSS' by Pringle . Annals of the Rheumatic Diseases. PMID 33060074 DOI: 10.1136/annrheumdis-2020-219096 |
0.345 |
|
| 2020 |
Rivière E, Pascaud J, Virone A, Dupré A, Ly B, Paoletti A, Seror R, Tchitchek N, Mingueneau M, Smith N, Duffy D, Cassard L, Chaput N, Pengam S, Gauttier V, ... ... Nocturne G, et al. Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33058491 DOI: 10.1002/art.41558 |
0.399 |
|
| 2020 |
Brito-Zerón P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, Praprotnik S, Nocturne G, Sebastian A, Fernandes Moça Trevisani V, Retamozo S, Acar-Denizli N, Wiland P, Sisó-Almirall A, Bootsma H, et al. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases. Clinical and Experimental Rheumatology. PMID 33025893 |
0.384 |
|
| 2020 |
Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Dupré A, Chen H, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. Annals of the Rheumatic Diseases. PMID 32843324 DOI: 10.1136/Annrheumdis-2019-216588 |
0.521 |
|
| 2020 |
Chevalier K, Belkhir R, Seror R, Mariette X, Nocturne G. Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone. Annals of the Rheumatic Diseases. PMID 32398282 DOI: 10.1136/Annrheumdis-2020-217481 |
0.526 |
|
| 2020 |
Dupré A, Collins M, Nocturne G, Carbonnel F, Mariette X, Seror R. Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab. Rheumatology (Oxford, England). PMID 32259251 DOI: 10.1093/rheumatology/keaa107 |
0.436 |
|
| 2020 |
Martin de Fremont G, Belkhir R, Henry J, Voisin AL, Lambotte O, Besson FL, Mariette X, Nocturne G. Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy. Annals of the Rheumatic Diseases. PMID 32188691 DOI: 10.1136/annrheumdis-2020-217225 |
0.34 |
|
| 2020 |
Cachen L, Nocturne G, Collins M, Meyer A, Carbonnel F, Mariette X, Seror R. Thu0382 Articular Manifestations In Patients With Inflammatory Bowel Diseases Treated With Anti-Tnfα Annals of the Rheumatic Diseases. 79: 425-425. DOI: 10.1136/Annrheumdis-2020-Eular.2563 |
0.516 |
|
| 2019 |
Leite Pereira A, Bitoun S, Paoletti A, Nocturne G, Marcos Lopez E, Cosma A, Le Grand R, Mariette X, Tchitchek N. Characterization of Phenotypes and Functional Activities of Leukocytes From Rheumatoid Arthritis Patients by Mass Cytometry. Frontiers in Immunology. 10: 2384. PMID 31681279 DOI: 10.3389/Fimmu.2019.02384 |
0.493 |
|
| 2019 |
Baber A, Nocturne G, Krzysiek R, Henry J, Belkhir R, Mariette X, Seror R. Large granular lymphocyte expansions in primary Sjögren's syndrome: characteristics and outcomes. Rmd Open. 5: e001044. PMID 31673421 DOI: 10.1136/Rmdopen-2019-001044 |
0.452 |
|
| 2019 |
Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, Mariette X, Nocturne G. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. Rmd Open. 5: e001033. PMID 31673417 DOI: 10.1136/Rmdopen-2019-001033 |
0.515 |
|
| 2019 |
Nocturne G, Pascaud J, Ly B, Tahmasebi F, Mariette X. JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis. Cellular & Molecular Immunology. PMID 31664224 DOI: 10.1038/s41423-019-0320-3 |
0.306 |
|
| 2019 |
Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Le Tiec C, Descamps E, Seror R, Mariette X. Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy. Rheumatology (Oxford, England). PMID 31613955 DOI: 10.1093/Rheumatology/Kez430 |
0.471 |
|
| 2019 |
Assan F, Seror R, Mariette X, Nocturne G. New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS. Annals of the Rheumatic Diseases. PMID 31501139 DOI: 10.1136/annrheumdis-2019-216222 |
0.379 |
|
| 2019 |
Paoletti A, Rohmer J, Ly B, Pascaud J, Rivière E, Seror R, Le Goff B, Nocturne G, Mariette X. Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors. Journal of Immunology (Baltimore, Md. : 1950). PMID 31484730 DOI: 10.4049/Jimmunol.1900386 |
0.452 |
|
| 2019 |
Sanosyan A, Daien C, Nutz A, Bollore K, Bedin AS, Morel J, Zimmermann V, Nocturne G, Peries M, Guigue N, Gottenberg JE, Van de Perre P, Mariette X, Tuaillon E. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome. Frontiers in Immunology. 10: 1153. PMID 31191532 DOI: 10.3389/Fimmu.2019.01153 |
0.533 |
|
| 2019 |
Nocturne G. [Sjögren's syndrome update: Clinical and therapeutic aspects]. La Revue De Medecine Interne. 40: 433-439. PMID 31027874 DOI: 10.1016/j.revmed.2019.03.329 |
0.309 |
|
| 2019 |
Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford, England). PMID 30838413 DOI: 10.1093/Rheumatology/Kez052 |
0.536 |
|
| 2019 |
Keraen J, Blanc E, Besson FL, Leguern V, Meyer C, Henry J, Belkhir R, Nocturne G, Mariette X, Seror R. Usefulness of F-FDG Positron Emission Tomography (PET) for the diagnosis of lymphoma in primary Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30615273 DOI: 10.1002/Art.40829 |
0.422 |
|
| 2019 |
Paoletti A, Reynaud F, Rohmer J, Pascaud J, Ly B, Rivière E, Tsapis N, Fattal E, Nocturne G, Mariette X. Sat0057 Increased Microrna-155 Is Associated With A Specific Defect Of Anti-Inflammatory M2 Macrophages Polarization Both In Human Rheumatoid Arthritis And In Collagen-Induced-Arthritis Mice Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.5415 |
0.449 |
|
| 2019 |
Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Ab0190 Crosstalk Between Salivary Gland Epithelial Cells And B Lymphocytes In Primary Sjögren’S Syndrome Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.4121 |
0.493 |
|
| 2019 |
Dupré A, Collins M, Carbonnel F, Mariette X, Nocturne G, Seror R. Sat0324 Articular Manifestations In Patients With Inflammatory Bowel Disease Treated With Vedolizumab Annals of the Rheumatic Diseases. 78: 1240-1241. DOI: 10.1136/Annrheumdis-2019-Eular.3969 |
0.495 |
|
| 2019 |
Houssais C, Noury J, Allenbach Y, Gallay L, Assan F, Benveniste O, Broner J, Duffau P, Espitia-Thibault A, Grasland A, Sanges S, Hayem G, Guern VL, Martis N, Marianpillai K, ... ... Nocturne G, et al. Sat0192 Myositis In Patients With Primary Sjögren’S Syndrome: Data From A French Nationwide Survey Annals of the Rheumatic Diseases. 78: 1171-1171. DOI: 10.1136/Annrheumdis-2019-Eular.3474 |
0.376 |
|
| 2019 |
Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Mariette X, Seror R. Ab0462 Immunizationto Rituximab Is More Frequent In Autoimmune Systemic Autoimmune Diseases Than In Rheumatoid Arthritis And May Be Managed By Switching From Rituximab To Ofatumumab Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.3343 |
0.475 |
|
| 2019 |
Paoletti A, Rohmer J, Ly B, Pascaud J, Riviere E, Nocturne G, Mariette X. P034 Presence of a specific defect in M2 polarization of blood monocytes from patients with rheumatoid arthritis, associated with increased microRNA-155 Annals of the Rheumatic Diseases. 78. DOI: 10.1136/Annrheumdis-2018-Ewrr2019.26 |
0.437 |
|
| 2018 |
Nocturne G, Seror R, Mariette X. Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands? Annals of the Rheumatic Diseases. PMID 30030264 DOI: 10.1136/Annrheumdis-2018-213979 |
0.496 |
|
| 2018 |
Bitoun S, Nocturne G, Ly B, Krzysiek R, Roques P, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Hacein-Bey-Abina S, Mackay F, et al. Methotrexate and BAFF interaction prevents immunization against TNF inhibitors. Annals of the Rheumatic Diseases. PMID 29936438 DOI: 10.1136/Annrheumdis-2018-213403 |
0.465 |
|
| 2018 |
Demaria L, Henry J, Seror R, Frenzel L, Hermine O, Mariette X, Nocturne G. Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS). British Journal of Haematology. PMID 29424433 DOI: 10.1111/Bjh.15120 |
0.448 |
|
| 2018 |
Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjögren syndrome. Nature Reviews. Rheumatology. PMID 29416129 DOI: 10.1038/Nrrheum.2018.1 |
0.49 |
|
| 2018 |
Rivière E, Tchitchek N, Nocturne G, Pascaud J, Boudaoud S, Thai A, Allaire N, Jagla B, Mingueneau M, Mariette X. P071/O13 RNA sequencing detection of gene dysregulation in B cells sorted from salivary gland tissue and from peripheral blood reveals new pathways involved in primary sjÖgren’s syndrome pathophysiology Annals of the Rheumatic Diseases. 77: 138-138. DOI: 10.1136/Annrheumdis-2018-Ewrr2019.60 |
0.481 |
|
| 2018 |
Bitoun S, Nocturne G, Ly B, Krzysiek R, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Bey SH, Pallardy M, Mariette X. P008 Methotrexate and baff interaction prevents immunisation against TNF-Α inhibitors by increasing adenosine and regulatory B-cells Annals of the Rheumatic Diseases. 77. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.34 |
0.499 |
|
| 2018 |
Virone A, Pascaud J, Riviere E, Gottenberg J, Guern VL, Mariette X, Nocturne G. O017 Il-7 in primary sjÖgren syndrome (PSS) is secreted by salivary gland epithelial cells after ifn stimulation and is associated with B-cell activation Annals of the Rheumatic Diseases. 77. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.17 |
0.427 |
|
| 2018 |
Rivière E, Tchitchek N, Nocturne G, Boudaoud S, Pascaud J, Virone A, Thai A, Allaire N, Jagla B, Mingueneau M, Mariette X. FRI0273 Rna sequencing detection of gene dysregulation in epithelial sorted cells from salivary gland tissue reveals interesting pathways involved in sjÖgren’s syndrome pathophysiology Annals of the Rheumatic Diseases. 77: 675-675. DOI: 10.1136/Annrheumdis-2018-Eular.3307 |
0.492 |
|
| 2017 |
Bitoun S, Roques P, Larcher T, Nocturne G, Serguera C, Chrétien P, Serre G, Grand RL, Mariette X. Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque. Frontiers in Immunology. 8: 1816. PMID 29326703 DOI: 10.3389/Fimmu.2017.01816 |
0.447 |
|
| 2017 |
Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, Bugge Tinggaard A, Renault V, Deleuze JF, Mariette X, Tost J. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. PMID 28916716 DOI: 10.1136/Annrheumdis-2017-211417 |
0.474 |
|
| 2017 |
Fogel O, Rivière E, Seror R, Nocturne G, Boudaoud S, Ly B, Gottenberg JE, Le Guern V, Dubost JJ, Nititham J, Taylor KE, Chanson P, Dieudé P, Criswell LA, Jagla B, et al. Role of the IL-12/IL-35 balance in Sjögren's syndrome. The Journal of Allergy and Clinical Immunology. PMID 28916184 DOI: 10.1016/J.Jaci.2017.07.041 |
0.416 |
|
| 2017 |
Schreiber K, Nocturne G, Cornec D, Daïen CI. Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal? Clinical Reviews in Allergy & Immunology. PMID 28560621 DOI: 10.1007/S12016-017-8614-7 |
0.395 |
|
| 2017 |
Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, Aouadi I, Kwemou M, Paul N, Pichot A, Locke J, Bowman SJ, Griffiths B, Sivils KL, Sibilia J, ... ... Nocturne G, et al. A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA. Human Molecular Genetics. PMID 28379387 DOI: 10.1093/Hmg/Ddx135 |
0.468 |
|
| 2017 |
Nocturne G, Seror R, Devauchelle-Pensec V, Saraux A, Mariette X, Chiche L. Prevalence of primary Sjögren Syndrome: What if Sjögren was right after all? Arthritis Care & Research. PMID 28217861 DOI: 10.1002/Acr.23223 |
0.439 |
|
| 2017 |
Nocturne G, Boudaoud S, Ly B, Pascaud J, Paoletti A, Mariette X. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. Journal of Autoimmunity. PMID 28214146 DOI: 10.1016/J.Jaut.2017.02.001 |
0.52 |
|
| 2017 |
Nocturne G, Seror R, Mariette X. Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor? Annals of the Rheumatic Diseases. 76: e3. PMID 27742658 DOI: 10.1136/Annrheumdis-2016-210566 |
0.511 |
|
| 2017 |
Nocturne G, Ly B, Boudaoud S, Bitoun S, Paoletti A, Seror R, Nicco C, Mackay F, Vincent F, Ferlicot S, Stimmer L, Roulland S, krzysiek R, Bey SH, Batteux F, et al. P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept Annals of the Rheumatic Diseases. 76: 182-183. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.52 |
0.476 |
|
| 2017 |
Bitoun S, Roques P, Larcher T, Nocturne G, Serguera C, Chrétien P, Serre G, Grand RL, Mariette X. FRI0081 A macaque model of rheumatoid arthritis by immunization with citrullinated peptides: lessons for the human disease Annals of the Rheumatic Diseases. 76. DOI: 10.1136/Annrheumdis-2017-Eular.2843 |
0.425 |
|
| 2016 |
Zhao L, Nocturne G, Haskett S, Boudaoud S, Lazure T, Le Pajolec C, Mariette X, Mingueneau M, Banerjee D. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 27803305 DOI: 10.1093/Rheumatology/Kew360 |
0.431 |
|
| 2016 |
Nocturne G, Cornec D, Seror R, Mariette X. Use of Biologics in Sjögren's Syndrome. Rheumatic Diseases Clinics of North America. 42: 407-17. PMID 27431344 DOI: 10.1016/J.Rdc.2016.03.001 |
0.501 |
|
| 2016 |
Mingueneau M, Boudaoud S, Haskett S, Reynolds TL, Nocturne G, Norton E, Zhang X, Constant M, Park D, Wang W, Lazure T, Le Pajolec C, Ergun A, Mariette X. Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation. The Journal of Allergy and Clinical Immunology. PMID 27045581 DOI: 10.1016/J.Jaci.2016.01.024 |
0.511 |
|
| 2016 |
Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort. Scientific Reports. 6: 18421. PMID 26785768 DOI: 10.1038/Srep18421 |
0.48 |
|
| 2016 |
Nocturne G, Seror R, Mariette X. Reply. Arthritis & Rheumatology (Hoboken, N.J.). 68: 1319-20. PMID 26749273 DOI: 10.1002/Art.39584 |
0.353 |
|
| 2016 |
Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Miceli Richard C, Mariette X. Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits. Annals of the Rheumatic Diseases. 75: 633-5. PMID 26659716 DOI: 10.1136/Annrheumdis-2015-208557 |
0.447 |
|
| 2016 |
Tomi AL, Belkhir R, Nocturne G, Desmoulins F, Berge E, Pavy S, Miceli-Richard C, Mariette X, Seror R. Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 68: 1245-50. PMID 26636425 DOI: 10.1002/Art.39534 |
0.537 |
|
| 2016 |
Nocturne G, Seror R, Fogel O, Belkhir R, Boudaoud S, Saraux A, Larroche C, Le Guern V, Gottenberg JE, Mariette X. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 67: 3226-33. PMID 26359802 DOI: 10.1002/Art.39315 |
0.551 |
|
| 2016 |
Miceli-Richard C, Wang-Renault SF, Boudaoud S, Busato F, Lallemand C, Bethune K, Belkhir R, Nocturne G, Mariette X, Tost J. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 75: 933-40. PMID 26183421 DOI: 10.1136/Annrheumdis-2014-206998 |
0.46 |
|
| 2016 |
Fogel O, Rivière E, Seror R, Nocturne G, Ly B, Boudaoud S, Gottenberg J, Dubost J, Le Guern V, Dieudé P, Chanson P, Nititham J, Taylor K, Criswell L, Mariette X, et al. AB0150 Understanding The Role of The IL12/iL35 Balance in Sjögren Syndrome Annals of the Rheumatic Diseases. 75: 948.1-948. DOI: 10.1136/Annrheumdis-2016-Eular.5756 |
0.363 |
|
| 2016 |
Nocturne G, Ly B, Boudaoud S, Seror R, Zitvogel L, Mariette X. FRI0179 anti-TNF Therapy Is Associated with An Impaired Function of Nk Cells and A Defective Immunosurveillance against B-Cell Lymphomas Annals of the Rheumatic Diseases. 75: 494.2-495. DOI: 10.1136/Annrheumdis-2016-Eular.4140 |
0.52 |
|
| 2016 |
Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Richard CM, Mariette X. Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: Comparison of different kits Annals of the Rheumatic Diseases. 75: 633-635. DOI: 10.1136/annrheumdis-2015-208557 |
0.395 |
|
| 2016 |
Nocturne G, Tahmasebi F, Boudaoud S, Ly B, Mariette X. Le tofacitinib impacte négativement la fonction des NK et leur activité anti-lymphomateuse Revue Du Rhumatisme. 83: A275-A276. DOI: 10.1016/S1169-8330(16)30645-7 |
0.415 |
|
| 2016 |
Nocturne G, Ly B, Boudaoud S, Seror R, Zitvogel L, Mariette X. Le traitement par anti-TNF impacte négativement la fonction des NK et leur activité anti-lymphomateuse Revue Du Rhumatisme. 83: A274. DOI: 10.1016/S1169-8330(16)30641-X |
0.432 |
|
| 2016 |
Nocturne G, Ly B, Boudaoud S, Seror R, Nicco C, Chereau C, Kavian N, Batteux F, Mackay F, Vincent F, Lazure T, Krzysiek R, Hacein-Bey S, Stimmer L, Ferlicot S, et al. Les souris BAFF transgéniques traitées par anti-TNF ont une augmentation du risque de lymphome sous anticorps monoclonaux et pas sous récepteur soluble Revue Du Rhumatisme. 83: A235-A236. DOI: 10.1016/S1169-8330(16)30563-4 |
0.427 |
|
| 2015 |
Nocturne G, Cornec D, Seror R, Mariette X. New biological therapies in Sjögren's syndrome. Best Practice & Research. Clinical Rheumatology. 29: 783-93. PMID 27107513 DOI: 10.1016/J.Berh.2016.02.009 |
0.511 |
|
| 2015 |
Nocturne G, Virone A, Ng WF, Le Guern V, Hachulla E, Cornec D, Daien C, Vittecoq O, Bienvenu B, Marcelli C, Wendling D, Amoura Z, Dhote R, Lavigne C, Fior R, et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26606524 DOI: 10.1002/Art.39518 |
0.538 |
|
| 2015 |
Nocturne G, Tarn J, Boudaoud S, Locke J, Miceli-Richard C, Hachulla E, Dubost JJ, Bowman S, Gottenberg JE, Criswell LA, Lessard CJ, Sivils KL, Carapito R, Bahram S, Seror R, et al. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma. Annals of the Rheumatic Diseases. PMID 26338037 DOI: 10.1136/Annrheumdis-2015-207731 |
0.506 |
|
| 2015 |
Seror R, Nocturne G, Lazure T, Hendel-Chavez H, Desmoulins F, Belkhir R, Ravaud P, Benbijja M, Poirier-Colame V, Taoufik Y, Mariette X. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study. Arthritis Research & Therapy. 17: 241. PMID 26336930 DOI: 10.1186/S13075-015-0750-Y |
0.503 |
|
| 2015 |
Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P, van der Heijde D, van Gaalen F, Berenbaum F, Mariette X, Briot K, Feydy A, Claudepierre P, Dieudé P, Nithitham J, et al. Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort. Plos One. 10: e0134974. PMID 26313358 DOI: 10.1371/Journal.Pone.0134974 |
0.444 |
|
| 2015 |
De Vita S, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study. Rheumatology (Oxford, England). 54: 2249-56. PMID 26242856 DOI: 10.1093/Rheumatology/Kev257 |
0.437 |
|
| 2015 |
Miceli-Richard C, Taylor KE, Nititham J, Seror R, Nocturne G, Boudaoud S, Dieude P, Constantin A, Devauchelle-Pensec V, Tobón GJ, Mariette X, Criswell LA. Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression. Annals of the Rheumatic Diseases. 74: 1480-1. PMID 25805736 DOI: 10.1136/Annrheumdis-2014-206530 |
0.482 |
|
| 2015 |
Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. British Journal of Haematology. 168: 317-27. PMID 25316606 DOI: 10.1111/Bjh.13192 |
0.538 |
|
| 2015 |
Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, Desmoulins F, Nocturne G, Ravaud P, De Vita S. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study. Annals of the Rheumatic Diseases. 74: 526-31. PMID 24347569 DOI: 10.1136/Annrheumdis-2013-203991 |
0.494 |
|
| 2015 |
Nocturne G, Virone A, Le Guern V, Hachulla E, Daien C, Cornec D, Vittecoq O, Boris B, Marcelli C, Lavigne C, Wendling D, Amoura Z, Dhote R, Gottenberg J, Seror R, et al. SAT0399 Chronic Antigenic Stimulation and Activity of the Disease Are Predictive of Lymphoma Development in Primary SjÖgren Syndrome: A Case Control Study of 64 Cases Annals of the Rheumatic Diseases. 74: 803.2-804. DOI: 10.1136/annrheumdis-2015-eular.6116 |
0.395 |
|
| 2015 |
Haskett S, Boudaoud S, Reynolds T, Nocturne G, Themeles M, Dunstan R, Zheng T, Mingueneau M, Xavier M. AB0170 Cytof Analysis of Lip Biopsies from SjÖgren's Subjects Identifies Dysregulated Immune and Non-Immune Cell Subsets Annals of the Rheumatic Diseases. 74: 947.2-947. DOI: 10.1136/Annrheumdis-2015-Eular.6043 |
0.388 |
|
| 2015 |
Nocturne G, Seror R, Fogel O, Dieudé P, Dubost J, Fauchais A, Goëb V, Hachulla E, Larroche C, Le Guern V, Morel J, Perdriger A, Puechal X, Rist S, Devauchelle-Pensec V, et al. OP0080 CXCL13 and CCL11 Serum Levels are Associated With Lymphoma Occurrence and Disease Activity in Primary Sjögren Syndrome: Data from the French Prospective Cohort Assessment Annals of the Rheumatic Diseases. 74: 99.1-99. DOI: 10.1136/Annrheumdis-2015-Eular.5149 |
0.536 |
|
| 2015 |
Gottenberg J, Seror R, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost J, Fauchais A, Goeb V, Hachulla E, Hatron P, Larroche C, Le Guern V, Micelli-Richard C, Morel J, Perdriger A, ... ... Nocturne G, et al. SAT0379 Is Fatigue Immune-Mediated in Primary SjÖgren's Syndrome? Data from the Prospective Assess Cohort Annals of the Rheumatic Diseases. 74: 796.2-796. DOI: 10.1136/annrheumdis-2015-eular.3949 |
0.39 |
|
| 2015 |
Vita SD, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. THU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study Annals of the Rheumatic Diseases. 74: 338-339. DOI: 10.1136/Annrheumdis-2015-Eular.3101 |
0.485 |
|
| 2014 |
Guellec D, Nocturne G, Tatar Z, Pham T, Sellam J, Cantagrel A, Saraux A. Should non-steroidal anti-inflammatory drugs be used continuously in ankylosing spondylitis? Joint, Bone, Spine : Revue Du Rhumatisme. 81: 308-12. PMID 24589253 DOI: 10.1016/J.Jbspin.2014.01.003 |
0.541 |
|
| 2014 |
Nocturne G, Boudaoud S, Besson C, Davi F, Canioni D, Cacoub P, Hermine O, Mariette X. Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF) Blood. 124: 1641-1641. DOI: 10.1182/Blood.V124.21.1641.1641 |
0.498 |
|
| 2014 |
Gottenberg J, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost J, Fauchais A, Goeb V, Hachulla E, Hatron P, Larroche C, Le Guern V, Morel J, Perdriger A, ... ... Nocturne G, et al. OP0218 Elevated Serum BAFF is Associated with an Increased Risk of Developing A New Systemic Complication: Data from the Prospective ASSESS Cohort Annals of the Rheumatic Diseases. 73: 145.1-145. DOI: 10.1136/Annrheumdis-2014-Eular.4266 |
0.4 |
|
| 2014 |
Guellec D, Nocturne G, Tatar Z, Pham T, Sellam J, Cantagrel A, Saraux A. Les anti-inflammatoires non stéroïdiens doivent-ils être utilisés de manière continue dans la spondylarthrite ankylosante ? Revue Du Rhumatisme. 81: 368-373. DOI: 10.1016/J.Rhum.2014.04.002 |
0.481 |
|
| 2013 |
Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F, Melki J, Lessard CJ, Sivils KL, Dubost JJ, Hachulla E, Gottenberg JE, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. Blood. 122: 4068-76. PMID 24159176 DOI: 10.1182/Blood-2013-05-503383 |
0.767 |
|
| 2013 |
Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Science Translational Medicine. 5: 195ra96. PMID 23884468 DOI: 10.1126/Scitranslmed.3005727 |
0.522 |
|
| 2013 |
Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nature Reviews. Rheumatology. 9: 544-56. PMID 23857130 DOI: 10.1038/Nrrheum.2013.110 |
0.494 |
|
| 2013 |
Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, ... ... Nocturne G, et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort. Plos One. 8: e59868. PMID 23717383 DOI: 10.1371/Journal.Pone.0059868 |
0.495 |
|
| 2013 |
Nocturne G, Boudaoud S, Miceli Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Criswell LA, Ma A, Busato F, Melki J, Dubost JJ, Hachulla E, Gottenberg JE, Lombes M, et al. OP0023 Germinal and Somatic Genetic Variants of TNFAIP3 Promote Lymphomagenesis Process Complicating Primary Sjögren’s Syndrome Annals of the Rheumatic Diseases. 72: A55.3-A56. DOI: 10.1136/Annrheumdis-2013-Eular.228 |
0.511 |
|
| 2012 |
Nocturne G, Seror R, Dubost J, Goeb V, Le Quellec A, Bienvenu B, Roux C, Hachulla E, Le Guern V, Saraux A, Gottenberg J, Mariette X. Étude de 44 cas de lymphome compliquant un syndrome de Sjögren primitif (SSp) La Revue De MéDecine Interne. 33: A34-A35. DOI: 10.1016/J.Revmed.2012.10.024 |
0.401 |
|
| 2011 |
Nocturne G, Pavy S, Lazure T, Taoufik Y, Miceli C, Mariette X. IgG4 multiorgan lymphoproliferative syndrome as a differential diagnosis of primary Sjogren's syndrome in men? Annals of the Rheumatic Diseases. 70: 2234-5. PMID 21646415 DOI: 10.1136/Ard.2011.150367 |
0.519 |
|
| 2010 |
Nocturne G, Sellam J, Miquel A, M'Bappé P, Berenbaum F. Is sarcoma a complication of arterial femoro-popliteal bypass? Joint, Bone, Spine : Revue Du Rhumatisme. 77: 358-60. PMID 20471894 DOI: 10.1016/J.Jbspin.2010.03.018 |
0.473 |
|
| 2010 |
Nocturne G, Dougados M, Constantin A, Richez C, Sellam J, Simon A, Wendling D, Mariette X, Gottenberg JE. Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Annals of the Rheumatic Diseases. 69: 471-2. PMID 20107035 DOI: 10.1136/ard.2008.107102 |
0.546 |
|
| 2010 |
Nocturne G, Sellam J, Miquel A, M’Bappé P, Berenbaum F. Le sarcome est-il une complication du pontage artériel fémoro-poplité ? Revue Du Rhumatisme. 77: 640-642. DOI: 10.1016/J.Rhum.2010.04.028 |
0.42 |
|
| Show low-probability matches. |